Answer
Cemiplimab (Libtayo) is administered by intravenous infusion over 30 minutes through a line containing a sterile, non-pyrogenic, low-protein-binding in-line or add-on filter with a pore size of 0.2–5 microns.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 24Document updated
Sources checked